Intravitreal pegaptanib resulted in significantly improved vision in patients with diabetic macular edema, making it an effective, well-tolerated treatment option, a study found.
Author: OphthalmologyWeb
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
After 55 Years, Surgery Restores Sight
After being hit in the eye by a stone, a detached retina left a man blind in his right eye. Despite surgery to remove a cataract when the man was 23, which temporarily restored light perception, the patient was completely blind in that eye. Doctors at …
Single-Piece IOLs May Cause Secondary Glaucoma
Single-piece acrylic IOLs that are malpositioned may cause glaucoma that is often not attributed to the IOL, according to a speaker here.
Diet Tied To Lower Risk Of Vision Loss In Old Age
For people at a higher risk of losing central vision as they age, eating sufficient levels of certain dietary nutrients could help protect their eyes.
Video Interview: Pearls for Ophthalmic Practice Building
Featured Article
Nearly Half Of All Patients Requiring Vision Correction Are Significantly Astigmatic, Study Shows
Nearly half of patients requiring vision correction are significantly astigmatic in at least one eye, new research shows. Data from the study further reveals that the prevalence of astigmatism is almost double in patients with myopia (nearsightedness) …
UC San Diego Names Robert N. Weinreb Chair Of Ophthalmology
Robert N. Weinreb, MD – a clinician, surgeon and scientist who is internationally renowned for his work with glaucoma – has been selected as the new chair of the department of Ophthalmology and director of the Shiley Eye Center at the University of Cal…
ACT Announces First Patients Enrolled In Two Clinical Trials Using Embryonic Stem Cells To Treat Stargardt’s Disease And Dry Age-Related Macular Degeneration
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today the enrollment of the first patients in its two Phase 1/2 clinical trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration …
PSivida Announces Phase I/II Clinical Study Evaluating Bioerodible, Sustained Release Latanoprost Device In Ocular Hypertension And Glaucoma
Drug delivery company pSivida Corp. (NASDAQ: PSDV) (ASX: PVA) today announced the commencement of a Phase I/II clinical trial studying a new bioerodible drug delivery implant for the treatment of glaucoma and ocular hypertension. The implant is designe…
Transmission Of Upper Respiratory Organisms During Anti-VEGF Injection May Warrant Enhanced Precaution
A study suggested that surgeons should wear a face mask or avoid talking during intravitreal injection of anti-VEGFs, as Streptococcal isolates may be roughly three times more common after these injections than after intraocular surgery.
Bazan Assumes Chair Of The ARVO Foundation For Eye Research
Nicolas G. Bazan, MD, PhD, FARVO, of Louisiana State University (LSU) Health Sciences Center in New Orleans, is the new chair of the ARVO Foundation for Eye Research (AFER). He succeeds Gary W. Abrams, MD, FARVO, of Wayne State University/Kresge Eye In…
Equipment Leasing Offers Attractive Options For Medical Practices, But Be Aware Of Risks, LeClairRyan Attorney Advises
Advances in medical technology offer many advantages to today’s physicians, but equipment is evolving so rapidly that practitioners need to think twice before purchasing it outright. Leasing presents an attractive alternative, but only to those who ful…
New Perspectives on Macular Degeneration Therapies
Featured Article
Researchers Report Progress Using IPS Cells To Reverse Blindness
Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as …
Study Estimates Potential For Ranibizumab To Prevent Blindness From Age-Related Macular Degeneration
A computer modeling study suggests that administering the drug ranibizumab is associated with reducing the magnitude of legal blindness and visual impairment caused by age-related macular degeneration in non-Hispanic white individuals, according to a r…
Expenditures For Glaucoma Medications Appear To Have Increased
CHICAGO – In recent years, spending for glaucoma medications has increased, especially for women, persons who have only public health insurance and those with less than a high school education, according to a report published Online First by Archives o…
Webinar – Selective Laser Trabeculoplasty (SLT): Maximizing Success, The Next Refractive Surgeon’s Laser
Featured Article
BCVA Results Better Maintained With Monthly Ranibizumab Treatments
Monthly injections with ranibizumab maintained best corrected visual acuity results better than did quarterly injections in patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration, according to a study.
Leading Glaucoma Experts comment on Octopus with EyeSuite’s ease of use and reliability
Octopus with EyeSuite is versatile, flexible and easy to use – learn how in this video